Common MS drugs taken together do not reduce relapse risk

(Wiley) A recent clinical trial found that interferonβ-1a and glatiramer acetate, two of the most commonly prescribed drugs for multiple sclerosis (MS), provide no additional clinical benefit when taken together.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news